Hello world!
Welcome to WordPress. This is your first post. Edit or delete it, then start writing!
Will I Get Paid if I Participate in a Clinical Trial for MBC?
Click to learn about money you may receive if you participate in a clinical trial, including whether you will be paid.
Mark Your 2026 Calendars!
Click for a calendar of upcoming in-person, virtual, and hybrid MBC conferences.
Mark Your 2026 Calendars!
Click for a calendar of upcoming in-person, virtual, and hybrid MBC conferences.
Experts Weigh in on MBC Subtypes: Triple Negative MBC, Including HER2-Low and HER2-Ultralow
This month, we highlight the latest expert opinions on treatments for triple negative and HER2-low and -ultralow MBC and unanswered questions that need to be answered in clinical trials. Click to learn more about clinical trials for this subtype of MBC.
San Antonio Breast Cancer Symposium 2025
The San Antonio Breast Cancer Symposium (SABCS) recently held its 2025 conference from December 9-12, 2025. Click to read MBC-related reports from this meeting.
San Antonio Breast Cancer Symposium 2025
The San Antonio Breast Cancer Symposium (SABCS) recently held its 2025 conference from December 9-12, 2025. Click to read MBC-related reports from this meeting.
Clinical Trial Support for Spanish Speakers
Resources are available to help Spanish-speakers with MBC learn about clinical trials. Click to learn more.
FDA Expands Approval for Enhertu®
The FDA expanded approval for fam-trastuzumab deruxtecan-nxki (Enhertu®) in combination with pertuzumab (Perjeta®) as first-line treatment of people with HER2+ MBC. Click to learn more about this new approval.
Medical CBD and MBC
CBD, a component of the cannabis plant that does not cause a “high,” may improve quality of life in people with MBC by reducing pain, nausea, anxiety, and sleep problems. Read below to learn more about testing of CBD in clinical trials for people with MBC.